Germany: Drug Spending Crack Down Could Mean Tougher Reference Pricing Measures
Pricing reforms in Germany could have a ripple effect elsewhere as other countries look for inspiration on how to reign in pharmaceutical spending.
You may also be interested in...
Big changes are in store on the drug pricing front in Germany. Further reforms could depend on who is appointed health minister.
Industry has warned that reforming the system for evaluating orphan drugs could have serious consequences for patient access.
Industry has have welcomed another delay to the implementation of drug pricing reforms that aim to lower Canadian drugs prices.